Hao-Yuan Mo

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun, Wen-Fei Li, Nian-Yong Chen et al. · The Lancet Oncology · 2016 · 950 citations

Medicine, Oncology, Radiation Oncology +14

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma

Lin-Quan Tang, Chao-Feng Li, Jing Li et al. · JNCI Journal of the National Cancer Institute · 2015 · 391 citations · Full text

Medicine, Oncology, Pathology +16

Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial

Qiu-Yan Chen, Yue-Feng Wen, Ling Guo et al. · JNCI Journal of the National Cancer Institute · 2011 · 333 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells

Li-Bing Song, Mu‐Sheng Zeng, Wenting Liao et al. · Cancer Research · 2006 · 330 citations · Full text

Medicine, Cell Biology, Oncology +16

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

Su-Mei Cao, Qi Yang, Ling Guo et al. · European Journal of Cancer · 2017 · 284 citations

Medicine, Oncology, Radiation Oncology +15